Serodiagnosis of American trypanosomosis by using nonpathogenic trypanosomatid antigen

15Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Crithidia luciliae, a nonpathogenic trypanosomatid, could provide a good alternative source of antigen for serodiagnosis of Chagas' disease. An enzyme-linked immunosorbent assay showed 100% sensitivity and 83% specificity when 91 human serum samples from Chagas' disease patients and 127 human serum samples from people suffering from toxoplasmosis (21 samples), leishmaniasis (32 samples), systemic rheumatic diseases (33 samples), and heart diseases (41 samples) were tested simultaneously with Trypanosoma cruzi and C. luciliae crude extracts. By Western blotting, an immunodominant band (30 kDa) was recognized by chagasic sera on the C. luciliae crude extract; specificity reached 97% with respect to this protein band. The carbohydrate moieties were not antigenic.

Cite

CITATION STYLE

APA

Monteon, V. M., Guzman-Rojas, L., Negrete-Garcia, C., Rosales-Encina, J. L., & Lopez, P. A. R. (1997). Serodiagnosis of American trypanosomosis by using nonpathogenic trypanosomatid antigen. Journal of Clinical Microbiology, 35(12), 3316–3319. https://doi.org/10.1128/jcm.35.12.3316-3319.1997

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free